"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ELVN. [ FAQ on what and how to ask] For non-ELVN questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Richard A. Fair
Headquarter: 6200 Lookout Road, Boulder, CO, United States, 80301
Industry: Biotechnology, Investment Track: immunity biotech, Employees: 60
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.
My Watchlist
